Valent’s sale of the Orthene insecticide product line to AMVAC reinforces portfolio strategy of both companies.
Valent U.S.A. Corp. and AMVAC Chemical Corp., a wholly owned subsidiary of American Vanguard Corp., have reached a definitive agreement on AMVAC’s acquisition of Valent’s Orthene insecticide product line which is expected to close by mid-January. Terms of the transaction were not disclosed.
The sale will allow Valent to focus on its current portfolio of crop protection products, as well as what many company officials consider the healthiest pipeline of new materials in the company’s 19-year history.
Under the agreement, AMVAC will take ownership of the assets of the Valent Orthene product line including all registrations, formulations, and existing inventories of the agricultural and professional product lines. The transfer of ownership will include proprietary formulation information, registration rights, marketing materials, certain intellectual property rights, and existing inventories of Orthene.